|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1999; 33:403-411 © 1999 by the American College of Cardiology Foundation |
a William Beaumont Hospital, Royal Oak, Michigan, USA
* Henry Ford Health System, Detroit, Michigan, USA
Manuscript received August 3, 1998; revised manuscript received September 2, 1998, accepted October 22, 1998.
Reprint requests and correspondence: Dr. Peter A. McCullough, Henry Ford Health System, One Ford Place, Suite 3C, Detroit, Michigan 48202
Objectives
This study was done to test the hypothesis that a forced diuresis with maintenance of intravascular volume after contrast exposure would reduce the rate of contrast-induced renal injury.
Background
We have previously shown a graded relationship with the degree of postprocedure renal failure and the probability of in-hospital death in patients undergoing percutaneous coronary intervention. Earlier studies of singular prevention strategies (atrial natriuretic factor, loop diuretics, dopamine, mannitol) have shown no clear benefit across a spectrum of patients at risk.
Methods
A prospective, randomized, controlled, single-blind trial was conducted where 98 participants were randomized to forced diuresis with intravenous crystalloid, furosemide, mannitol (if pulmonary capillary wedge pressure <20 mm Hg), and low-dose dopamine (n = 43) versus intravenous crystalloid and matching placebos (n = 55).
Results
The groups were similar with respect to baseline serum creatinine (2.44 ± 0.80 and 2.55 ± 0.91 mg/dl), age, weight, diabetic status, left ventricular function, degree of prehydration, contrast volume and ionicity, and extent of peripheral vascular disease. The forced diuresis resulted in higher urine flow rate (163.26 ± 54.47 vs. 122.57 ± 54.27 ml/h) over the 24 h after contrast exposure (p = 0.001). Two participants in the experimental arm versus five in the control arm required dialysis, with all seven cases having measured flow rates <145 ml/h in the 24 h after the procedure. The mean individual change in serum creatinine at 48 h, the primary end point, was 0.48 ± 0.86 versus 0.51 ± 0.87, in the experimental and control arms, respectively, p = 0.87. There were no differences in the rates of renal failure across six definitions of renal failure by intent-to-treat analysis. However, in all participants combined, the rise in serum creatinine was related to the degree of induced diuresis after controlling for baseline renal function, r = –0.36, p = 0.005. The rates of renal failure in those with urine flow rates greater than 150 ml/h in the postprocedure period were significantly lower, 8/37 (21.6%) versus 28/61 (45.9%), p = 0.03.
Conclusions
Forced diuresis with intravenous crystalloid, furosemide, and mannitol if hemodynamics permit, beginning at the start of angiography provides a modest benefit against contrast-induced nephropathy provided a high urine flow rate can be achieved.
This article has been cited by other articles:
|
|
 |
|
  S. D. Weisbord, M. K. Mor, A. L. Resnick, K. C. Hartwig, P. M. Palevsky, and M. J. Fine Incidence and Outcomes of Contrast-Induced AKI Following Computed Tomography Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1274 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Baumgarten and J. H. Ellis Contrast-Induced Nephropathy: Contrast Material Not Required? Am. J. Roentgenol., August 1, 2008; 191(2): 383 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. McCullough Contrast-Induced Acute Kidney Injury J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1419 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Kelly, B. Dwamena, P. Cronin, S. J. Bernstein, and R. C. Carlos Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy Ann Intern Med, February 19, 2008; 148(4): 284 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Wilson and J. T. Willerson Myocardial Revascularization with Percutaneous Devices Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598. [Full Text]
|
|
|
|
|
|
S. D. Weisbord and P. M. Palevsky Prevention of Contrast-Induced Nephropathy with Volume Expansion Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 273 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Heyman, S. Rosen, and C. Rosenberger Renal Parenchymal Hypoxia, Hypoxia Adaptation, and the Pathogenesis of Radiocontrast Nephropathy Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 288 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. C. Wong and M. G. Irwin Contrast-induced nephropathy Br. J. Anaesth., October 1, 2007; 99(4): 474 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Solomon Contrast media nephropathy--how to diagnose and how to prevent? Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1812 - 1815. [Full Text] [PDF]
|
|
|
|
 |
|
 A. O Onbasili, Y. Yeniceriglu, P. Agaoglu, A. Karul, T. Tekten, H. Akar, and G. Discigil Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures Heart, June 1, 2007; 93(6): 698 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pannu, N. Wiebe, M. Tonelli, and for the Alberta Kidney Disease Network Prophylaxis Strategies for Contrast-Induced Nephropathy JAMA, June 21, 2006; 295(23): 2765 - 2779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tepel, P. Aspelin, and N. Lameire Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach Circulation, April 11, 2006; 113(14): 1799 - 1806. [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Barrett and P. S. Parfrey Preventing Nephropathy Induced by Contrast Medium N. Engl. J. Med., January 26, 2006; 354(4): 379 - 386. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Goldenberg and S. Matetzky Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies Can. Med. Assoc. J., May 24, 2005; 172(11): 1461 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Friedrich, N. Adhikari, M. S. Herridge, and J. Beyene Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death Ann Intern Med, April 5, 2005; 142(7): 510 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Gleeson and S. Bulugahapitiya Contrast-Induced Nephropathy Am. J. Roentgenol., December 1, 2004; 183(6): 1673 - 1689. [Full Text] [PDF]
|
|
|
|
|
|
K. Spargias, E. Alexopoulos, S. Kyrzopoulos, P. Iacovis, D. C. Greenwood, A. Manginas, V. Voudris, G. Pavlides, C. E. Buller, D. Kremastinos, et al. Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention Circulation, November 2, 2004; 110(18): 2837 - 2842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Cox and J. P. Tsikouris Preventing Contrast Nephropathy: What Is the Best Strategy? A Review of the Literature J. Clin. Pharmacol., April 1, 2004; 44(4): 327 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Rezkalla Contrast Nephropathy Clin. Med. Res., October 1, 2003; 1(4): 301 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Herzog How to Manage the Renal Patient with Coronary Heart Disease: The Agony and the Ecstasy of Opinion-Based Medicine J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2556 - 2572. [Full Text] [PDF]
|
|
|
|
|
|
R. L. Mehta and G. M. Chertow Acute Renal Failure Definitions and Classification: Time for Change? J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2178 - 2187. [Full Text] [PDF]
|
|
|
|
|
|
G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and Management of Patients Undergoing Percutaneous Coronary Revascularization Ann Intern Med, July 15, 2003; 139(2): 123 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kay Acetylcysteine and Renal Function Following Coronary Angiographic Procedures--Reply JAMA, June 4, 2003; 289(21): 2796 - 2796. [Full Text] [PDF]
|
|
|
|
|
|
D. C. Balderramo Acetylcysteine and Renal Function Following Coronary Angiographic Procedures JAMA, June 4, 2003; 289(21): 2795 - 2796. [Full Text] [PDF]
|
|
|
|
|
|
J. Kay, W. H. Chow, T. M. Chan, S. K. Lo, O. H. Kwok, A. Yip, K. Fan, C. H. Lee, and W. F. Lam Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention: A Randomized Controlled Trial JAMA, February 5, 2003; 289(5): 553 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lameire, R. Vanholder, and W. Van Biesen Loop Diuretics for Patients With Acute Renal Failure: Helpful or Harmful? JAMA, November 27, 2002; 288(20): 2599 - 2601. [Full Text] [PDF]
|
|
|
|
 |
|
 H Yamazaki, H Oi, M Matshushita, T Inoue, H Nakamura, and T Inoue Renal cortical retention of contrast medium on delayed CT and nephropathy following transcatheter arterial chemoembolisation in patients with high serum creatinine level Br. J. Radiol., November 1, 2002; 75(899): 874 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-G. i Shyu, J.-J. Cheng, and P. Kuan Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1383 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. M. Esnault Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1362 - 1364. [Full Text] [PDF]
|
|
|
|
|
|
C. Briguori, F. Manganelli, P. Scarpato, P. P. Elia, B. Golia, G. Riviezzo, S. Lepore, M. Librera, B. Villari, A. Colombo, et al. Acetylcysteine and contrast agent-associated nephrotoxicity J. Am. Coll. Cardiol., July 17, 2002; 40(2): 298 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mueller, G. Buerkle, H. J. Buettner, J. Petersen, A. P. Perruchoud, U. Eriksson, S. Marsch, and H. Roskamm Prevention of Contrast Media-Associated Nephropathy: Randomized Comparison of 2 Hydration Regimens in 1620 Patients Undergoing Coronary Angioplasty Arch Intern Med, February 11, 2002; 162(3): 329 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D O Kessel, I Robertson, J V Patel, S Simpson, and E J Taylor Angiographic strategies when iodinated contrast medium is undesirable Imaging, December 15, 2001; 13(5): 349 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Yamazaki, H Oi, M MatSushita, T Kim, E Tanaka, T Inoue, H Nakamura, T Teshima, and T Inoue Renal cortical retention on delayed CT and nephropathy following transcatheter arterial chemoembolisation Br. J. Radiol., August 1, 2001; 74(884): 695 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. LAMEIRE and R. VANHOLDER Pathophysiologic Features and Prevention of Human and Experimental Acute Tubular Necrosis J. Am. Soc. Nephrol., February 1, 2001; 12(90001): 20S - 32. [Abstract] [Full Text]
|
|
|
|
|
|
L. Gruberg, G. S. Mintz, R. Mehran, G. Dangas, A. J. Lansky, K. M. Kent, A. D. Pichard, L. F. Satler, and M. B. Leon The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tepel, M. van der Giet, C. Schwarzfeld, U. Laufer, D. Liermann, and W. Zidek Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal Function by Acetylcysteine N. Engl. J. Med., July 20, 2000; 343(3): 180 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. MURPHY, B. J. BARRETT, and P. S. PARFREY Contrast Nephropathy J. Am. Soc. Nephrol., January 1, 2000; 11(1): 177 - 182. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
